ACTIVE

AMPACIMON

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-4,3 M €
-1294.5% YoY
Revenue
3,6 M €
-43.4% YoY
Equity
8,7 M €
-33.5% YoY
Workforce
38,9 ETP
-0.5% YoY

What does AMPACIMON do?

AMPACIMON is a Public limited company incorporated in 2010. Its main activity is: Manufacture of instruments and appliances for measuring, testing and navigation. Its registered office is in Liège. It employs on average 38,9 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0827.990.317
Incorporation
22/07/2010
Legal form
Public limited company
Registered office
Boulevard de Patience et Beaujonc 3 box 43
4000 Liège · WallonieSee on map
Contributed capital
16 420 410,44 €
Latest accounts
31/12/2025
Average workforce
38,9 ETP
Activities (NACE)
26510Manufacture of instruments and appliances for measuring, testing and navigation· main26510Manufacture of instruments and appliances for measuring, testing and navigation71121Engineering activities and related technical consultancy71121Engineering activities and related technical consultancy
Joint committees (1)
  • 209
Signals
Solid equityLow riskGood liquidityHealthy social debtsHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 15 financial years

202520242023202220212020201920182017201620152014201320122011
Income statement
Revenue3,6 M €6,4 M €–––––––––––––
EBITDA-2,9 M €-728,6 k €-196,4 k €-381,5 k €246,1 k €1,4 M €384,5 k €-77 k €1,6 M €497,7 k €319,8 k €260,7 k €-291,9 k €-22,4 k €337,3 k €
Operating result-4,1 M €-899,9 k €-1,8 M €-1,2 M €-407,8 k €745,1 k €-413,3 k €-557,1 k €1,3 M €466,9 k €286,7 k €250,5 k €-389,3 k €-135,2 k €169,6 k €
Net result-4,3 M €-305,8 k €-3,2 M €-968,8 k €-295,3 k €670,7 k €-378,2 k €-527,8 k €1,1 M €333,9 k €277,5 k €242,9 k €-397,9 k €-137,1 k €92,3 k €
Balance sheet
Equity8,7 M €13,1 M €13,5 M €6,6 M €7,6 M €7,6 M €2,7 M €3,1 M €3,6 M €2,6 M €2,6 M €640,9 k €398 k €495,9 k €633 k €
Total assets11,1 M €16,3 M €16,5 M €9,7 M €10,7 M €10,7 M €5,6 M €6,1 M €6,9 M €5,8 M €5,3 M €1,7 M €681,1 k €976 k €1,3 M €
Cash32,4 k €86,5 k €102,2 k €458,3 k €1,4 M €2,9 M €112,1 k €828,8 k €3,3 M €2,3 M €2,7 M €1,5 M €190,1 k €305,9 k €377,6 k €
Debts1,7 M €2,3 M €1,7 M €2,1 M €1,9 M €1,8 M €1,4 M €1,3 M €911,8 k €1,4 M €800,4 k €909,6 k €283,2 k €461,6 k €625,7 k €
Other
Workforce38,9 ETP39,1 ETP34,4 ETP28,9 ETP24,3 ETP18,9 ETP17,6 ETP14,6 ETP9,3 ETP5,9 ETP5,2 ETP5,0 ETP5,6 ETP5,0 ETP2,8 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 7 active · 39 ended

Active mandates

Indranil Chatterjee

Director · since 01 novembre 2025 · until 25 mai 2027

Active
FREDERIC VASSORT

Director · since 28 mai 2024 · until 28 mai 2030

Active
Junction Growth Partners

Director · since 13 octobre 2023 · until 13 octobre 2029 · 0782.660.732

Represented by Mermans Pieter-Jan

Active
NOSHAQ

Director · since 30 mai 2023 · until 30 mai 2029 · 0426.624.509

Represented by BAR Loic

Active
CREOS Luxembourg SA (e)

Director · since 09 novembre 2022 · until 09 novembre 2028

Represented by Zenner Laurence

Active
Guus KEDER

Director · since 10 août 2020 · until 10 août 2026

Active
KORYS MANAGEMENT

Director · since 10 août 2020 · until 10 août 2026 · 0885.971.571

Represented by Karel Van Cleemput

Active

Ended mandates

Indranil CHATTERJEE

Director · since 01 novembre 2023 · until 01 novembre 2025

Ended
Junction Growth Partners

Director · since 13 octobre 2023 · until 13 octobre 2029 · 0782.660.732

Represented by Pieter-Jan MERMANS

Ended
NOSHAQ

Director · since 30 mai 2023 · until 30 mai 2029 · 0426.624.509

Represented by THOMAS GÉRALD

Ended
CREOS LUXEMBOURG SA

Director · since 09 novembre 2022 · until 09 novembre 2028

Represented by Seywert CLAUDE

Ended
At this address

Other companies at this address

CompanyCBE no.
Abscint● Active
0749.828.410
Amyl Therapeutics● Active
0758.775.372
BECARV● Bankrupt
0840.777.885
BE.SPINE● Active
1013.110.857
CEFALY Technology● Active
0870.578.661
DERMAX● Active
0667.730.677
DIANOSIC● Active
1034.558.646
DW Cefaly Holding● Active
0725.837.241
EARTH ALIVE CLEAN TECHNOLOGIES BELGIUM● Active
1023.778.481
EXO Biologics● Active
0732.982.379
ExoXpert● Active
1003.807.666
Hirundo Biosciences● Active
0681.855.065
HolyFox Invest● Active
1010.693.181
Hyloris● Active
0669.738.676
Hyloris Developments● Active
0542.737.368
Hyloris Pharmaceuticals● Active
0674.494.151
Hyloris Therapeutics● Active
1025.029.385
LEGIAPARK● Active
0728.589.170
MAN & SCIENCE● Active
0837.403.770
ONCORADIOMICS● Active
0662.719.440
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/05/202624/06/202527/06/202407/06/202312/07/202208/07/2021
General meeting26/05/202627/05/202528/05/202430/05/202331/05/202208/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

15 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202526/05/202629/05/2026FrenchPDF
Full model31/12/202427/05/202524/06/2025FrenchPDF
Abridged model31/12/202328/05/202427/06/2024FrenchPDF
Abridged model31/12/202230/05/202307/06/2023FrenchPDF
Abridged model31/12/202131/05/202212/07/2022FrenchPDF
Abridged model31/12/202008/06/202108/07/2021FrenchPDF
Abridged model31/12/201926/05/202026/08/2020FrenchPDF
Abridged model31/12/201827/05/201908/08/2019FrenchPDF
Abridged model31/12/201729/05/201817/07/2018FrenchPDF
Abridged model31/12/201617/05/201706/07/2017FrenchPDF
Abridged model31/12/201528/04/201615/06/2016FrenchPDF
Abridged model31/12/201428/04/201512/08/2015FrenchPDF
Abridged model31/12/201328/05/201423/06/2014FrenchPDF
Abridged model31/12/201223/04/201312/08/2013FrenchPDF
Abridged model31/12/201124/04/201214/08/2012FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 7 active · 39 ended

Active mandates

Indranil Chatterjee

Director · since 01 novembre 2025 · until 25 mai 2027

Active
FREDERIC VASSORT

Director · since 28 mai 2024 · until 28 mai 2030

Active
Junction Growth Partners

Director · since 13 octobre 2023 · until 13 octobre 2029 · 0782.660.732

Represented by Mermans Pieter-Jan

Active
NOSHAQ

Director · since 30 mai 2023 · until 30 mai 2029 · 0426.624.509

Represented by BAR Loic

Active
CREOS Luxembourg SA (e)

Director · since 09 novembre 2022 · until 09 novembre 2028

Represented by Zenner Laurence

Active
Guus KEDER

Director · since 10 août 2020 · until 10 août 2026

Active
KORYS MANAGEMENT

Director · since 10 août 2020 · until 10 août 2026 · 0885.971.571

Represented by Karel Van Cleemput

Active

Ended mandates

Indranil CHATTERJEE

Director · since 01 novembre 2023 · until 01 novembre 2025

Ended
Junction Growth Partners

Director · since 13 octobre 2023 · until 13 octobre 2029 · 0782.660.732

Represented by Pieter-Jan MERMANS

Ended
NOSHAQ

Director · since 30 mai 2023 · until 30 mai 2029 · 0426.624.509

Represented by THOMAS GÉRALD

Ended
CREOS LUXEMBOURG SA

Director · since 09 novembre 2022 · until 09 novembre 2028

Represented by Seywert CLAUDE

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Registered office11/09/2026
    Î1 Changement d'adresse - Effet le 15/09/2026 '
    PDF
  • Mandates01/09/2026
    Remplacement du représentant permanent d'un administrateur
    PDF
  • Other26/08/2026
    Renouvellement mandats
    PDF
  • Mandates05/06/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/09/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates19/09/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates05/07/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates14/05/2024
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-4,3 M €↓
  2. 2024
    Annual accounts 2024-305,8 k €↑
  3. 2023
    Annual accounts 2023-3,2 M €↓
  4. 2022
    Annual accounts 2022-968,8 k €↓
  5. 2021
    Annual accounts 2021-295,3 k €↓
  6. 2020
    Annual accounts 2020670,7 k €↑
  7. 2019
    Annual accounts 2019-378,2 k €↑
  8. 2018
    Annual accounts 2018-527,8 k €↓
  9. 2017
    Annual accounts 20171,1 M €↑
  10. 2016
    Annual accounts 2016333,9 k €↑
  11. 2015
    Annual accounts 2015277,5 k €↑
  12. 2014
    Annual accounts 2014242,9 k €↑
  13. 2013
    Annual accounts 2013-397,9 k €↓
  14. 2012
    Annual accounts 2012-137,1 k €↓
  15. 2011
    Annual accounts 201192,3 k €
  16. 22/07/2010
    IncorporationPublic limited company